When To See a Doctor

The skin redness may not always necessitate a visit to the doctor. For example, moderate sunburn can be treated at home by using moisturizers and consuming plenty of water.
Some causes of red skin, however, necessitate medical treatment. If the rash persists, see a doctor.
- arises suddenly and spreads quickly
- blisters
- becomes painful
- shows clinical manifestations of inflammation, such as feeling warm or generating pus or other fluids
- persists for several days
- covers vast portions of the body
If you have a persistent skin condition like eczema, rosacea, seborrheic dermatitis, or psoriasis, talk to your doctor about how you can reduce stress, avoid irritants, and keep your symptoms under control.
Burns, allergic responses, and infections are just a few of the causes of skin redness. A doctor should see skin redness that lasts more than a few days or recurs. If the rash is excruciating or occurs in conjunction with other more severe symptoms, they should seek medical attention.
Some skin diseases are chronic, with symptoms recurring regularly. These disorders may require lifelong treatment, including both drugs and lifestyle adjustments.
References
- E. Lee, C. Cho, and J. Ha, “Biophysical properties of redness-prone skin in Korean women,” J. Cosmet. Dermatol., Dec. 2021, doi: 10.1111/JOCD.14722.
- J. F. Scott et al., “Oral Vitamin D Rapidly Attenuates Inflammation from Sunburn: An Interventional Study,” J. Invest. Dermatol., vol. 137, no. 10, pp. 2078–2086, Oct. 2017, doi: 10.1016/J.JID.2017.04.040.
- J. L. Ryan et al., “Curcumin for Radiation Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Thirty Breast Cancer Patients,” Radiat. Res., vol. 180, no. 1, pp. 34–43, Jul. 2013, doi: 10.1667/RR3255.1.
- J. W. Ely and M. S. Stone, “The Generalized Rash: Part II. Diagnostic Approach,” Am. Fam. Physician, vol. 81, no. 6, pp. 735–739, Mar. 2010.
- A. Rendon and K. Schäkel, “Psoriasis Pathogenesis and Treatment,” Int. J. Mol. Sci. 2019, Vol. 20, Page 1475, vol. 20, no. 6, p. 1475, Mar. 2019, doi: 10.3390/IJMS20061475.
- K. G. Blumenthal et al., “Patient Characteristics and Concerns about Drug Allergy: A Report from the United States Drug Allergy Registry,” J. Allergy Clin. Immunol. Pract., vol. 8, no. 9, pp. 2958–2967, Oct. 2020, doi: 10.1016/J.JAIP.2020.08.018.
- S. Basetti, J. Hodgson, T. M. Rawson, and A. Majeed, “Scarlet fever: a guide for general practitioners,” http://dx.doi.org/10.1080/17571472.2017.1365677, 2017, doi: 10.1080/17571472.2017.1365677.
- S. N. Bains, P. Nash, and L. Fonacier, “Irritant Contact Dermatitis,” Clin. Rev. Allergy Immunol. 2018 561, vol. 56, no. 1, pp. 99–109, Oct. 2018, doi: 10.1007/S12016-018-8713-0.
- “Seborrheic Dermatitis and Dandruff: A Comprehensive Review,” J. Clin. Investig. Dermatology, vol. 3, no. 2, 2015, doi: 10.13188/2373-1044.1000019.
- B. Vijayalakshmi and D. Ganapathy, “Medical management of cellulitis,” Res. J. Pharm. Technol., vol. 9, no. 11, pp. 2067–2070, Nov. 2016, doi: 10.5958/0974-360X.2016.00422.4.



